Analysis shows elevated neutrophils and lipid profile changes in albino mice, indicating potential risks of copper oxides and their biomedical applications.
The current study explores the synthesis, characterization and toxicity of copper oxides (CuO-NPs) in albino mice. The nanoparticles exhibited a porous, rough-surfaced, spherical morphology; XRD confirmed their crystalline nature, while FTIR revealed key functional groups of CuO-NPs. The 30 days H1 (5 mg/kg) and H2 (15 mg/kg) CuO-NPs exposure induced significant alterations in haematological parameters, including elevated white blood cell counts, particularly neutrophils, platelets and a significant decrease in haemoglobin and platelets distribution width. Biochemical analyses revealed changes in lipid profile, kidney, and liver biomarkers, indicating potential toxicity. Histological studies of the liver indicated sinusoidal lumen, necrosis, opening of the central vein, lymphocytic infiltration, irregular nucleus, degeneration of hepatocytes, and antinucleosis. In the kidney, glomerular destruction, necrosis, tubular degeneration, vascular degeneration, anisokaryosis, and expansion of the central vein were recorded. The heart tissues showed congestion, fatty degeneration, infiltration of inflammatory cells, and necrosis in the treated group. Molecular interactions revealed CuO NPs interacted with albumin, AST, bilirubin, and fibrinogen via hydrogen and covalent bonds, showing potential toxicity. This study highlights the link between nanomaterial properties, physiological changes, and molecular interactions underlying CuO NP toxicity, emphasizing the need for further research on their safe use and biomedical applications.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: